SARS-CoV-2 hijacks antiviral human proteins to enter human cells

by American Society for MicrobiologyTransmission electron micrograph of SARS-CoV-2 virus particles isolated from a patient. Credit: NIAIDSARS-CoV-2 depends on the broadly antiviral interferon-ind

Updated on: April 22,2024 20

SARS-CoV-2 hijacks antiviral human proteins to enter human cells

by American Society for MicrobiologyTransmission electron micrograph of SARS-CoV-2 virus particles isolated from a patient. Credit: NIAIDSARS-CoV-2 depends on the broadly antiviral interferon-ind

Updated on:April 22,2024 20

Antibodies produced by SARS-CoV-2 variants vary in ability to neutralise other variants of the virus

by The Francis Crick InstituteColorized scanning electron micrograph of an apoptotic cell (green) heavily infected with SARS-COV-2 virus particles (yellow), isolated from a patient sample. Image

Updated on: April 22,2024 19

Antibodies produced by SARS-CoV-2 variants vary in ability to neutralise other variants of the virus

by The Francis Crick InstituteColorized scanning electron micrograph of an apoptotic cell (green) heavily infected with SARS-COV-2 virus particles (yellow), isolated from a patient sample. Image

Updated on:April 22,2024 19

Immunological memory after SARS-CoV-2 infection recovery

by University of FreiburgColorized scanning electron micrograph of an apoptotic cell (green) heavily infected with SARS-COV-2 virus particles (yellow), isolated from a patient sample. Image captu

Updated on: April 22,2024 15

Immunological memory after SARS-CoV-2 infection recovery

by University of FreiburgColorized scanning electron micrograph of an apoptotic cell (green) heavily infected with SARS-COV-2 virus particles (yellow), isolated from a patient sample. Image captu

Updated on:April 22,2024 15

How does SARS-CoV-2 evade our immune defenses?

by John Hewitt , Medical XpressColorized scanning electron micrograph of a cell (blue) heavily infected with SARS-CoV-2 virus particles (red), isolated from a patient sample. Image captured at the NIA

Updated on: April 22,2024 20

How does SARS-CoV-2 evade our immune defenses?

by John Hewitt , Medical XpressColorized scanning electron micrograph of a cell (blue) heavily infected with SARS-CoV-2 virus particles (red), isolated from a patient sample. Image captured at the NIA

Updated on:April 22,2024 20

Antibodies to SARS-CoV-2 remain stable, or even increase, seven months after infection

by Barcelona Institute for Global HealthColorized scanning electron micrograph of a cell (blue) heavily infected with SARS-CoV-2 virus particles (red), isolated from a patient sample. Image captu

Updated on: April 22,2024 15

Antibodies to SARS-CoV-2 remain stable, or even increase, seven months after infection

by Barcelona Institute for Global HealthColorized scanning electron micrograph of a cell (blue) heavily infected with SARS-CoV-2 virus particles (red), isolated from a patient sample. Image captu

Updated on:April 22,2024 15

SARS-CoV-2 mutations come and go, and physicians' advice remains the same: Please vaccinate

by Kelley Luckstein,Mayo ClinicThis is an illustration of a SARS-CoV-2 particle, top left. To the right of the particle, the viral genome is stretched out. Genes are represented by boxes of diff

Updated on: April 22,2024 11

SARS-CoV-2 mutations come and go, and physicians' advice remains the same: Please vaccinate

by Kelley Luckstein,Mayo ClinicThis is an illustration of a SARS-CoV-2 particle, top left. To the right of the particle, the viral genome is stretched out. Genes are represented by boxes of diff

Updated on:April 22,2024 11

Individuals with immunodeficiency at high risk of mortality following SARS-CoV-2 infection

by University of BirminghamCredit: Pixabay/CC0 Public DomainPatients with primary and secondary immunodeficiency are at higher risk of mortality following SARS-CoV-2 infection compared with the g

Updated on: April 22,2024 18

Individuals with immunodeficiency at high risk of mortality following SARS-CoV-2 infection

by University of BirminghamCredit: Pixabay/CC0 Public DomainPatients with primary and secondary immunodeficiency are at higher risk of mortality following SARS-CoV-2 infection compared with the g

Updated on:April 22,2024 18

SARS-CoV-2 studies: Only neutralizing antibodies allow conclusions to be drawn about protection against new infections

by Medical University of ViennaPrinciple of cell-culture-based neutralization assays. (A) Conventional virus-neutralization test (VNT) and (B) pseudovirus-neutralization test (pVNT) are laborator

Updated on: April 22,2024 12

SARS-CoV-2 studies: Only neutralizing antibodies allow conclusions to be drawn about protection against new infections

by Medical University of ViennaPrinciple of cell-culture-based neutralization assays. (A) Conventional virus-neutralization test (VNT) and (B) pseudovirus-neutralization test (pVNT) are laborator

Updated on:April 22,2024 12

How SARS-CoV-2 evades the immune system

by Hokkaido UniversityThe expression of the immune response gene NLRC5 (red purple) is suppressed in SARS-CoV-2 (green) infected cells (Photo: Koichi Kobayashi). Credit: Koichi KobayashiResearche

Updated on: April 22,2024 12

How SARS-CoV-2 evades the immune system

by Hokkaido UniversityThe expression of the immune response gene NLRC5 (red purple) is suppressed in SARS-CoV-2 (green) infected cells (Photo: Koichi Kobayashi). Credit: Koichi KobayashiResearche

Updated on:April 22,2024 12

SARS-CoV-2 mutations can complicate immune surveillance of human T-killer cells

by CeMM Research Center for Molecular Medicine of the Austrian Academy of SciencesGraphical representation of T cell recognizing and killing SARS-CoV-2 infected cell (top). Mutant SARS-CoV-2 is not pr

Updated on: April 22,2024 19

SARS-CoV-2 mutations can complicate immune surveillance of human T-killer cells

by CeMM Research Center for Molecular Medicine of the Austrian Academy of SciencesGraphical representation of T cell recognizing and killing SARS-CoV-2 infected cell (top). Mutant SARS-CoV-2 is not pr

Updated on:April 22,2024 19

SARS-CoV-2 infections may trigger antibody responses against multiple virus proteins

by Public Library of ScienceCredit: Pixabay/CC0 Public DomainAll coronaviruses produce four primary structural proteins and multiple nonstructural proteins. However, the majority of antibody-base

Updated on: April 22,2024 12

SARS-CoV-2 infections may trigger antibody responses against multiple virus proteins

by Public Library of ScienceCredit: Pixabay/CC0 Public DomainAll coronaviruses produce four primary structural proteins and multiple nonstructural proteins. However, the majority of antibody-base

Updated on:April 22,2024 12

SARS-CoV-2 induces inflammation, cytokine storm and stress in infected lung cells

by Heinrich-Heine University DuesseldorfThe coronavirus SARS-CoV-2 docks with its spike protein onto the receptor-ACE2 found on the surface of lung cells. The levels of co-expressed genes with the hum

Updated on: April 22,2024 14

SARS-CoV-2 induces inflammation, cytokine storm and stress in infected lung cells

by Heinrich-Heine University DuesseldorfThe coronavirus SARS-CoV-2 docks with its spike protein onto the receptor-ACE2 found on the surface of lung cells. The levels of co-expressed genes with the hum

Updated on:April 22,2024 14